US20060211096A1 - Enzyme catalysis in the presence of ionic liquids - Google Patents
Enzyme catalysis in the presence of ionic liquids Download PDFInfo
- Publication number
- US20060211096A1 US20060211096A1 US11/440,321 US44032106A US2006211096A1 US 20060211096 A1 US20060211096 A1 US 20060211096A1 US 44032106 A US44032106 A US 44032106A US 2006211096 A1 US2006211096 A1 US 2006211096A1
- Authority
- US
- United States
- Prior art keywords
- aryl
- alkyl
- reaction medium
- ionic liquid
- substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 0 *n1ccn(C)c1 Chemical compound *n1ccn(C)c1 0.000 description 6
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/003—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions
- C12P41/004—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by ester formation, lactone formation or the inverse reactions by esterification of alcohol- or thiol groups in the enantiomers or the inverse reaction
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/62—Carboxylic acid esters
Definitions
- the invention relates to compositions comprising an enzyme and ionic liquids as well as a method for carrying out enzyme-catalysed reactions in the presence of ionic liquids.
- ionic liquids are melting salts which represent a new class of solvents having a non-molecular ionic character.
- ionic liquids have no measurable vapour pressure. This is a major advantage from the process engineering point of view because in this way, the distillative separation of a reaction mixture is possible as an effective method for product separation.
- Ionic liquids are temperature-stable up to above 200° C.
- cation and anion it is possible to gradually adjust the polarity and thereby tune the solubility properties.
- the range goes from water-miscible ionic liquids through water-immiscible ionic liquids as far as those which themselves form two phases with organic solvents.
- the skilful utilisation of the extraordinary solubility properties is the key to the successful use of ionic liquids as a new class of solvents.
- Ionic liquids have already been successfully used as new types of media in two-phase catalysis or as the medium for liquid-liquid extraction). (P. Wasserscheid, W. Keim, Angew. Chem. 2000, 112, 3926).
- ionic liquids can be used as co-solvents to improve the solubility of educts and products.
- the invention relates to a method for the conversion of substances (educts) in the presence of enzymes as a catalyst in a reaction medium comprising ionic liquids.
- the ionic liquid can be miscible with water or immiscible with water. In the same way, it is possible to carry out a single-phase, two-phase or multi-phase reaction.
- the ionic liquids comprise compounds having the general formula [A] n + [Y] n ⁇ , where
- n 1 or 2
- the anion [Y] n ⁇ is selected from the group comprising tetrafluoroborate ([BF 4 ] ⁇ ), tetrachloroborate ([BCl 4 ] ⁇ ), hexafluorophosphate ([PF 6 ] ⁇ ), hexafluoroantimonate ([SbF 6 ] ⁇ ), hexafluoroarsenate ([AsF 6 ] ⁇ ), tetrachloroaluminate ([AlCl 4 ] ⁇ ), trichlorozincate [(ZnCl 3 ] ⁇ ), dichlorocuprate, sulphate ([SO 4 ] 2 ⁇ ), carbonate ([CO 3 ] 2 ⁇ ), fluorosulphonate, [(R′—COO] ⁇ , [R′—SO 3 ] ⁇ or [(R′—SO 2 ) 2 N] ⁇ , and R′ is a linear or branched aliphatic
- the invention relates to a composition
- a composition comprising an enzyme and at least one of the ionic liquids defined above.
- These compositions can be used au the starting point for carrying out the afore-mentioned enzymatically catalyzed reactions.
- the compositions according to the invention can also contain the educts (substrate) to be converted and as the reaction proceeds, naturally also the reaction products obtainable by the enzymatic reaction.
- a still further aspect is thus the use of ionic liquids, especially the ionic liquids defined above, as the reaction medium or a constituent of the reaction medium in biocatalysis, i.e., carrying out enzymatically catalysed reactions on substrates.
- alkyl, aryl, arylalkyl and alkylaryl sulphonate groups can be substituted by halogen atoms, especially fluorine, chlorine or bromine.
- halogen atoms especially fluorine, chlorine or bromine.
- perfluorinated alkyl and afore-mentioned aryl sulphonates such as trifluoromethane sulphonate (triflate).
- triflate trifluoromethane sulphonate
- alkyl, aryl, arylalkyl and alkylaryl carboxylate groups can be substituted by halogen atoms, especially fluorine, chlorine or bromine.
- fluorinated, in particular the perfluorinated alkyl and above-mentioned aryl carboxylates such as trifluoromethane carboxylate (trifluoroacetate; CF 3 COO ⁇ ),
- trifluoromethane carboxylate trifluoroacetate; CF 3 COO ⁇
- the C 1 -C 6 -alkyl groups mentioned in connection with the substituents can be replaced by C 2 -C 4 -alkyl groups independently of each other.
- the C 1 -C 6 -alkoxy groups mentioned in connection with the substituents can be replaced by C 2 -C 4 -alkoxy groups independently of each other.
- the C 5 -C 12 -aryl groups mentioned in connection with the substituents can be replaced by C 6 -C 10 -aryl groups independently of each other and the C 3 -C 8 -heteroaryl groups can be replaced by C 3 -C 6 -heteroaryl groups independently of one another.
- the halogen atoms with which the alkyl, alkoxy and aryl groups can be substituted are selected from fluorine, chlorine, bromine and iodine, preferably fluorine, chlorine and bromine.
- radical R′ is a linear or branched aliphatic or alicyclic alkyl containing 1 to 8 carbon atoms or a C 6 -C 10 -aryl, C 6 -C 10 -aryl-C 1 -C 4 -alkyl or C 1 -C 4 -alkyl-C 6 -C 10 -aryl radical which can be substituted by halogen atoms.
- the cations [A] are, for example, selected from trimethylphenyl ammonium, methyltrioctyl ammonium, tetrabutyl-phosphonium, 3-butyl-1-methyl-imidazolium, 3-ethyl-1-methyl-imidazolium, N-butyl pyridinium, N-ethyl pyridinium, diethyl pyrazolium, 1-ethyl-3-methylimidazolium, 1-butyl-3-methylimidazolium, 1-hexyl-3-methylimidazolium, 1-octyl-3-methylimidazolium, 1-decyl-3-methylimidazolium, 1-butyl-4-methylpyridinium, 1-butyl-3-methylpyridinium, 1-butyl-2-methylpyridinium, 1-butyl-pyridinium, butyl-methyl-imidazolium, nonyl-methyl-imidazolium, butyl-methyl
- Ionic liquids and their production are known in the prior art.
- the corresponding halide salt [cation] + X ⁇ is first formed and isolated by reacting an amine NR 1 R 2 R 3 , a phosphane PR 1 R 2 R 3 , an imidazole derivative having the general formula R 1 R 2+ N ⁇ CR 3 —R 5 —R 3 C ⁇ N + R 1 R 2 or a pyridinium derivative having the general formula R 1 R 2 N ⁇ CR 3 R 4+ with an alkyl chloride, alkyl bromide or alkyl iodide (F.
- the halide salt is converted by the addition of a metal salt MY (with precipitation or separation of the salt MX or the product [A] + [Y] ⁇ from the respective solvent used)
- [Y] ⁇ stands for a hexafluorophosphate, tetrafluoroborate, bis(trifluoromethyl sulphonyl)amide, perfluoroalkyl sulphonate and perfluoroalkyl carboxylate ion
- M + stands for an alkali cation
- the ionic liquid is used as the only reaction medium, i.e., free from further solvents.
- the fraction of the ionic liquid in the reaction medium can however be between 0.1 and 99.9 percent by volume, preferably between 5 and 75 percent by volume, more preferably between 15 or 50 and 75 percent by volume relative to the total quantity of the reaction medium.
- the reaction medium can also contain a further solvent.
- a further solvent can be selected from the group consisting of water, buffer solutions (pH 2 to 10, preferably 5 to 8) and organic solvents.
- Usable organic solvents are miscible with water or immiscible with water.
- organic solvents mention may be made of methyl-tert-butyl ether, toluene, hexane, heptane, tert-butanol, glycols, polyalkylene glycols.
- fundamentally all conventional solvents known in the field of enzyme catalysis can be considered.
- ionic liquids offers significant advantages, such as, for example, an increase in the activity in the case of formate dehydrogenase, a significant increase in the yield in reactions with galactosidase, an increase in the enantioselectivity for lipases and an improvement in the educt volubility for hydrophobic educts.
- the enzyme together with the total quantity of ionic liquid or a part thereof can be used repeatedly or in continuously operated reactors.
- the enzymes can be selected from the class of oxidoreductases for regio- and stereoselective oxidation and reduction, from the class of glycosidases for the synthesis of oligosaccharides, from the class of lipases to obtain optically active products (among others, alcohols, amines, carboxylic acids) and from the class of lyases for synthesis, and hydrolases.
- the method according to the invention can be carried out at temperatures between ⁇ 10° C. and 130° C., preferably in a temperature range between 10° C. and 80° C., especially preferably in a temperature range between 20° C. and 40° C.
- the method can be carried out in a single-phase fashion or in a multiphase reaction system,
- ionic liquids can be added to the reaction medium to increase the educt solubility.
- formate dehydrogenase used for cofactor regeneration an increase in the reaction rate compared with the purely aqueous system is observed in the same concentration range of the ionic liquid (see Example 1). No deactivation of the enzyme was observed even when the time of influence of the ionic liquid was fairly long.
- ionic liquids offer a valuable possibility for increasing the productivity of enzymatic reactions through an increase in the educt concentration. This is especially interesting for barely soluble to very barely soluble educts such as aromatic ketones or steroids.
- glycosidases have not only been used for breaking bonds between saccharides but also for the synthesis of di- and oligosaccharides.
- water-miscible solvents leads to reduced enzyme stability
- yields no greater than 31% have been obtained even in the most recent studies (J. H. Yoon, J. S. Rhee, Carbohydr. Res. 2000, 327, 377; M. J. Hernaiz, D. H. G. Crout, J. Mol. Cat. B 2000, 10, 403).
- the main problem in these reactions is the immediately initiated secondary hydrolysis of the product, catalysed by the same enzyme.
- the galactosidage is very stable in the presence of ionic liquids and can be repeatedly used after separation by means of ultrafiltration without any change in the attainable yield and the product formation rate.
- Ionic liquids also offer advantages in reverse hydrolysis for the synthesis of di- and oligosaccharides.
- high educt concentrations together with additives, usually organic solvents, are used to reduce the water activity.
- ionic liquids especially offer the advantage of a very good dissolving capacity for carbohydrates.
- the enzyme has so far conventionally been separated by filtration and the reaction solution conventionally separated by distillation and the solvent fed back.
- ionic liquids permits direct distillative separation of the reactands from the reaction mixture even in the presence of the enzyme so that a simplified procedure results. If the reactands possess suitable volatility, this procedure is not limited to lipases.
- the conversion rate and the enantioselectivity are in some cases significantly improved, in individual cases a factor of 5 better.
- the reaction in tert-butylmethyl ether which is also used as a solvent for lipase-catalysed reactions in industrial processes, is used for comparison.
- the FDH-catalysed oxidation of formic acid to carbon dioxide by the reduction of nicotinamide adenine dinucleotide (NAD + to NADH+H + ) is used as the test reaction to determine the enzyme activity.
- NAD + to NADH+H + nicotinamide adenine dinucleotide
- the increase in NADH with time at 25° C. is detected photometrically at a wavelength of 340 nm.
- composition of the enzyme assay 1 ml buffer solution (50 mM triethanolamine hydrochloride, 1 mM dithiothreitol, hydrochloric acid) pH 7 is mixed with 0.1 ml of aqueous sodium formate solution (2.4 M) and 0.1 ml of enzyme solution (0.7 mg/ml, 8.4 U).
- the enzyme solution already contains the cofactor NAD (6 mM)
- composition of the reaction mixture 0.05 ml buffer solution (65 mM KH 2 PO 4 , 195 mM K 2 HPO 4 ) pH 7,3 is mixed with 0.5 ml N-acetyl glucosamine solution (GlcNAc 600 mM or 1.2 M in buffer solution), 0.25 ml lactose solution (250 mM in buffer solution) and 0.2 ml enzyme solution (10 mg/ml in buffer solution).
- UV detector (205 nm) TABLE 3 Enantioselective acylation of 1-phenyl ethanol, catalysed by lipase from Candida antarctica (Type B): conversion and enantiomer excess in ionic liquids compared to the standard reaction in tert-butylmethyl ether; Ionic liquid/solvent Conversion Enantiomer excess NMIm + PF 6 ⁇ ⁇ + BMIm + BF 4 ⁇ + + HMIm + BF 4 ⁇ ⁇ + OMIm + BF 4 ⁇ + + 4-MBP + BF 4 ⁇ + + BMIm + CF 3 SO 3 ⁇ + + BMIm + (CF 3 SO 2 ) 2 N ⁇ + + + good to better, ⁇ the same, ⁇ poor to none.
- Example 3 Each 5 mg of lyophilised lipase (>30 U/mg) is mixed with 0.4 ml of a substrate solution as in Example 3. The further procedure corresponds to that described in Example 3.
- TABLE 4 Enantioselective acylation of 1-phenyl ethanol, catalysed by lipase from Candida antarctica (Type A): Conversion and enantiomer excess in ionic liquids compared to the standard reaction in tert-butylmethyl ether; Ionic liquid/solvent Conversion Enantiomer excess BMIm + PF 6 ⁇ + + NMIm + PF 6 ⁇ + + BMIm + BF 4 ⁇ ⁇ + HMIm + BF 4 ⁇ + + OMIm + BF 4 ⁇ + ⁇ BMIm + CF 3 SO 3 ⁇ + + + good to better, ⁇ the same, ⁇ poor to none.
- Example 3 Each 3 mg of lyophilised lipase (400 U/mg) is mixed with 0.4 ml of a substrate solution as in Example 3. The further procedure corresponds to that described in Example 3.
- TABLE 5 Enantioselective acylation of 1-phenyl ethanol, catalysed by lipase from Pseudomonas sp.: conversion and enantiomer excess in ionic liquids compared to the standard reaction in tert-butylmethyl ether; Ionic liquid/solvent Conversion Enantiomer excess MIm + PF 6 ⁇ ⁇ + 4-MBP + BF 4 ⁇ ⁇ + BMIm + CF 3 SO 3 ⁇ + + BMIm + (CF 3 SO 2 ) 2 N ⁇ + + + good to better, ⁇ the same, ⁇ poor to none.
- lyophilised lipase 600 mg is mixed with 4 ml of ionic liquid (BMIm + (CF 3 SO 2 ) 2 N ⁇ ), 1.2 ml of vinyl acetate and 0.7 ml 1-phenyl ethanol and thoroughly mixed. The reaction mixture is incubated for 40 min at 40° C.
- the enzyme/ionic liquid mixture is cooled, re-mixed with 1.2 ml of vinyl acetate and 0.7 ml of 1-phenyl ethanol and again incubated for 40 min at 40° C.
- reaction sequence involving incubation and distilling off can be repeated many times without the lipase activity diminishing.
- the fraction of ionic liquid is increased from 0 to 100 percent by volume. As a result of water traces in the ionic liquid and the educts, a water content of 0.6% is obtained for 100% ionic liquid. After 24 hours, the conversion no longer increases.
- the following lactose yields are obtained depending on the quantity of ionic liquid: Fraction of ionic liquid in % Yield [%] 0 0 10 0 20 0 30 4 40 12 50 15 60 15 70 16 80 16 90 16 100 17
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
Abstract
The invention relates to the implementation of enzyme-catalysed reactions in the presence of ionic liquids.
Description
- The invention relates to compositions comprising an enzyme and ionic liquids as well as a method for carrying out enzyme-catalysed reactions in the presence of ionic liquids.
- To date, enzymes have become firmly established as biocatalysts for reactions on the laboratory and industrial scale. Nevertheless, despite all the success with enzymatic reactions, there are still problems such as, for example,
-
- low productivities as a result of too low educt solubilities;
- low yields in equilibrium reactions;
- insufficient selectivity in regio- and stereoselective conversions;
- product inhibition;
- the occurrence of side reactions (parallel, consecutive reactions)
- There are known attempts to solve this problem by adding organic solvents (G. Carrea, S. Riva, Angew. Chem. 2000, 112, 2312; J. M. S. Cabral, M. R. Aires-Barros, H. Pinheiro, D. M. F. Prazeres, J. Biotechnol. 1997, 59, 133; M. N. Gupta, Eur. J. Biochem. 1992, 203, 25), by adding salts (A. M. Blinkorsky, Y. L. Khmelnitzky, J. S. Dordick, J. Am. Chem. Soc. 1999, 116, 2697) or by carrying out the reaction in microemulsions (B. Orlich, R. Schomäcker 1999, 65, 357-362). Frequently however, the improvements achieved thereby are not significant and do not justify the additional expenditure, or the enzyme stability decreases severely under these conditions (G. Carrea, S. Riva, Angew. Chem. 2000, 112, 2312). At low temperatures (<100° C.) ionic liquids are melting salts which represent a new class of solvents having a non-molecular ionic character. Although the first representatives have been known since 1914, ionic liquids have only been investigated intensively as solvents for chemical conversions in the last 15 years. Ionic liquids have no measurable vapour pressure. This is a major advantage from the process engineering point of view because in this way, the distillative separation of a reaction mixture is possible as an effective method for product separation. The known problems caused by azeotrope formation between solvents and products do not occur. Ionic liquids are temperature-stable up to above 200° C. By means of a suitable choice of cation and anion, it is possible to gradually adjust the polarity and thereby tune the solubility properties. The range goes from water-miscible ionic liquids through water-immiscible ionic liquids as far as those which themselves form two phases with organic solvents. The skilful utilisation of the extraordinary solubility properties is the key to the successful use of ionic liquids as a new class of solvents.
- Ionic liquids have already been successfully used as new types of media in two-phase catalysis or as the medium for liquid-liquid extraction). (P. Wasserscheid, W. Keim, Angew. Chem. 2000, 112, 3926).
- According to the invention a substantial increase in the yield and selectivity was surprisingly established during the conversion of a wide range of educts with different enzymes in the presence of ionic liquids, which represents a significant improvement compared with the prior art. No adverse effects of the ionic liquid on the enzyme stability were established and in individual cases, even a stabilising effect was found.
- This is unexpected and surprising bearing in mind the ionic nature of the ionic liquids and the strong interactions thereby possible between the ionic liquids and the enzyme with its likewise charged groups.
- It was also found that ionic liquids can be used as co-solvents to improve the solubility of educts and products.
- The invention relates to a method for the conversion of substances (educts) in the presence of enzymes as a catalyst in a reaction medium comprising ionic liquids.
- The ionic liquid can be miscible with water or immiscible with water. In the same way, it is possible to carry out a single-phase, two-phase or multi-phase reaction.
- The ionic liquids comprise compounds having the general formula
[A]n +[Y]n−,
where - n=1 or 2 and
- the anion [Y]n− is selected from the group comprising tetrafluoroborate ([BF4]−), tetrachloroborate ([BCl4]−), hexafluorophosphate ([PF6]−), hexafluoroantimonate ([SbF6]−), hexafluoroarsenate ([AsF6]−), tetrachloroaluminate ([AlCl4]−), trichlorozincate [(ZnCl3]−), dichlorocuprate, sulphate ([SO4]2−), carbonate ([CO3]2−), fluorosulphonate, [(R′—COO]−, [R′—SO3]− or [(R′—SO2)2N]−, and R′ is a linear or branched aliphatic or alicyclic alkyl containing 1 to 12 carbon atoms or a C5-C18-aryl, C5-C18-aryl-C1-C6-alkyl or C1-C6-alkyl-C5-C18-aryl radical that can be substituted by halogen atoms, the cation [A]+ is selected from
-
- quaternary ammonium cations having the general formula
[NR1R2R3R]+, - phosphonium cations having the general formula
[PR1R2R3R]+, - imidazolium cations having the general formula
- where the imidizole nucleus can be substituted with at least one group selected from C1-C6-alkyl, C1-C6-alkoxy, C1-C6-aminoalkyl, C5-C12-aryl or C5-C12-aryl-C1-C6-alkyl groups,
- pyridinium cations having the general formula
- where the pyridine nucleus can be substituted with at least one group selected from C1-C6-alkyl, C1-C6-alkoxy, C1-C6-aminoalkyl, C5-C12-aryl or C5-C12-aryl-C1-C6-alkyl groups,
- pyrazolium cations having the general formula
- where the pyrazole nucleus can be substituted with at least one group selected from C1-C6-alkyl, C1-C6-alkoxy, C1-C6-aminoalkyl, C5-C12-aryl or C5-C12-aryl-C1-C6-alkyl groups,
- and triazolium cations having the general formula
- where the triazole nucleus can be substituted with at least one group selected from C1-C6-alkyl, C1-C6-alkoxy, C1-C6-aminoalkyl, C5-C12-aryl or C5-C12-aryl-C1-C6-alkyl groups,
- and the radicals R1, R2, R3 are selected independently of one another from the group consisting of
- hydrogen;
- linear or branched, saturated or unsaturated, aliphatic or alicyclic alkyl groups with 1 to 20 carbon atoms;
- heteroaryl, heteroaryl-C1-C6-alkyl groups with 3 to 8 carbon atoms in the heteroaryl radical and at least one heteroatom selected from N, O and S which can be substituted with at least one group selected from C1-C6-alkyl groups and/or halogen atoms;
- aryl-, aryl-C1-C6-alkyl groups with 5 to 12 carbon atoms in the aryl radical which if necessary can be substituted with at least one C1-C6-alkyl group and/or one halogen atom.
- quaternary ammonium cations having the general formula
- In a further aspect the invention relates to a composition comprising an enzyme and at least one of the ionic liquids defined above. These compositions can be used au the starting point for carrying out the afore-mentioned enzymatically catalyzed reactions. Accordingly, in addition to the enzyme (biocatalyst), the compositions according to the invention can also contain the educts (substrate) to be converted and as the reaction proceeds, naturally also the reaction products obtainable by the enzymatic reaction.
- A still further aspect is thus the use of ionic liquids, especially the ionic liquids defined above, as the reaction medium or a constituent of the reaction medium in biocatalysis, i.e., carrying out enzymatically catalysed reactions on substrates.
- In a particular development of the invention the alkyl, aryl, arylalkyl and alkylaryl sulphonate groups (anion [Y]) can be substituted by halogen atoms, especially fluorine, chlorine or bromine. Especially preferred are the perfluorinated alkyl and afore-mentioned aryl sulphonates such as trifluoromethane sulphonate (triflate). As non-halogenated representatives mention may be made of methane sulphonate, benzene sulphonate and the toluene sulphonate group as well as other sulphonate leaving groups known in the prior art.
- In a further development of the invention the alkyl, aryl, arylalkyl and alkylaryl carboxylate groups can be substituted by halogen atoms, especially fluorine, chlorine or bromine. Especially preferred are the fluorinated, in particular the perfluorinated alkyl and above-mentioned aryl carboxylates, such as trifluoromethane carboxylate (trifluoroacetate; CF3COO−), As non-halogenated representatives mention may be made of the acetate and benzoate group as well as all other carboxylate leaving groups known in the prior art.
- In preferred developments of the invention the C1-C6-alkyl groups mentioned in connection with the substituents can be replaced by C2-C4-alkyl groups independently of each other. Likewise, the C1-C6-alkoxy groups mentioned in connection with the substituents can be replaced by C2-C4-alkoxy groups independently of each other. In a further alternative of the invention the C5-C12-aryl groups mentioned in connection with the substituents can be replaced by C6-C10-aryl groups independently of each other and the C3-C8-heteroaryl groups can be replaced by C3-C6-heteroaryl groups independently of one another. The halogen atoms with which the alkyl, alkoxy and aryl groups can be substituted are selected from fluorine, chlorine, bromine and iodine, preferably fluorine, chlorine and bromine.
- In a preferred development the radical R′ is a linear or branched aliphatic or alicyclic alkyl containing 1 to 8 carbon atoms or a C6-C10-aryl, C6-C10-aryl-C1-C4-alkyl or C1-C4-alkyl-C6-C10-aryl radical which can be substituted by halogen atoms.
- The cations [A] are, for example, selected from trimethylphenyl ammonium, methyltrioctyl ammonium, tetrabutyl-phosphonium, 3-butyl-1-methyl-imidazolium, 3-ethyl-1-methyl-imidazolium, N-butyl pyridinium, N-ethyl pyridinium, diethyl pyrazolium, 1-ethyl-3-methylimidazolium, 1-butyl-3-methylimidazolium, 1-hexyl-3-methylimidazolium, 1-octyl-3-methylimidazolium, 1-decyl-3-methylimidazolium, 1-butyl-4-methylpyridinium, 1-butyl-3-methylpyridinium, 1-butyl-2-methylpyridinium, 1-butyl-pyridinium, butyl-methyl-imidazolium, nonyl-methyl-imidazolium, butyl-methyl-imidazolium, hexyl-methyl-imidazolium, octyl-methyl-imidazolium, 4-methyl-butyl-pyridinium, triethyl ammonium, triethylmethyl ammonium, butylmethyl-pyridinium, propyl ammonium, methyl-methyl-imidazolium, ethyl-methyl-imidazolium, butyl-methyl-imidazolium.
- Ionic liquids and their production are known in the prior art. For the synthesis of ionic liquids using hexafluorophosphate, tetrafluoroborate, bis(trifluoromethylsulphonyl),amide, perfluoroalkyl sulphonate and perfluoroalkyl carboxylate ions, the corresponding halide salt [cation]+X− is first formed and isolated by reacting an amine NR1R2R3, a phosphane PR1R2R3, an imidazole derivative having the general formula R1R2+N═CR3—R5—R3C═N+R1R2 or a pyridinium derivative having the general formula R1R2N═CR3R4+ with an alkyl chloride, alkyl bromide or alkyl iodide (F. H. Hurley, T. P. Wier, Jr., J. Electrochem. Soc. 1951, 98, 207-212; J. S. Wilkes, J. A. Levisky, R. A. Wilson, C. L. Hussey, Inorg. Chem. 1982, 21, 1263-1264; A. A. K. Abdul-Sada, P. W. Ambler, P. K. G. Hodgson, K. R. Seddon, N. J. Steward, WO-A-95/21871) R. H. Dubois, M. J. Zaworotko, P. S. White, Inorg. Chem. 1989, 28, 2019-2020; J. F. Knifton, J. Mol. Catal. 1987, 43, 65-78; C. P. M. Lacroix, F. H. M. Dekker, A. G. Talma, J. W. F. Seetz, EP-A-0989134). Starting from the [A]+X− halide salt which has been formed and isolated, two different paths are known for the synthesis of ionic liquids using hexafluorophosphate, tetrafluoroborate, bis(trifluoromethyl sulphonyl)-amide, perfluoroalkyl sulphonate and perfluoroalkyl carboxylate ions. On the one hand, the halide salt is converted by the addition of a metal salt MY (with precipitation or separation of the salt MX or the product [A]+[Y]− from the respective solvent used) where [Y]− stands for a hexafluorophosphate, tetrafluoroborate, bis(trifluoromethyl sulphonyl)amide, perfluoroalkyl sulphonate and perfluoroalkyl carboxylate ion and M+ stands for an alkali cation (J. S. Wilkes, M. J. Zaworotko, J. Chem. Soc. Chem. Commun. 1992, 965-967; Y. Chauvin, L. Mugmann, H. Olivier, Angew. Chem. 1995, 107, 2941-2943) P. A. Z. Suarez, J. E. L. Dullius, S. Einloft, R. F. de Souza, J. Dupont, Polyhedron, 1996, 15, 1217-1219) P. Bonhôte, A.- P. Dias, N. Papageorgiou, K. Kalyanasundaram, M. Grätzel, Inorg. Chem. 1996, 35, 1168-1178; C. M. Gordon, J. D. Holbrey, A. R. Kennedy, K. R. Seddon, J. Mater. Chem. 1998, 8, 2627-2638) P. A. Z. Suarez, S. Einloft, J. E. L. Dullius, R. F. de Souza, J. Dupont, J. Chim. Phys. 1998, 95, 1626-1639; A. J. Carmichael, C. Mardacre, J. D. Holbrey, M. Nieuwenhuyzen, K. R. Seddon, Anal. Chem. 1999, 71, 4572-4574; J. D. Holbrey, K. R. Seddon, J. Chem. Soc., Dalton Trans. 1999, 2133-2140). On the other hand, by the addition of a strong acid H+ [Y]− the halide ion is displaced with the release of H+X− and exchanged for [Y]−, where [Y]− here stands for a hexafluorophosphate, tetrafluoroborate, bis(trifluoromethylaulphonyl)amide, perfluoroalkyl sulphonate and perfluoroalkyl carboxylate ion (J. Fuller, R. T. Carlin, H. C. de Long, D. Haworth, J. Chem. Soc. Chem. Commun. 1994, 299-300). However, ionic liquids can especially advantageously be produced halide-free using the method described in EP 00118441.5.
- In a development of the method according to the invention the ionic liquid is used as the only reaction medium, i.e., free from further solvents. The fraction of the ionic liquid in the reaction medium can however be between 0.1 and 99.9 percent by volume, preferably between 5 and 75 percent by volume, more preferably between 15 or 50 and 75 percent by volume relative to the total quantity of the reaction medium.
- In addition to the ionic liquid, the reaction medium can also contain a further solvent. This can be selected from the group consisting of water, buffer solutions (pH 2 to 10, preferably 5 to 8) and organic solvents. Usable organic solvents are miscible with water or immiscible with water. As examples of organic solvents mention may be made of methyl-tert-butyl ether, toluene, hexane, heptane, tert-butanol, glycols, polyalkylene glycols. In addition, however, fundamentally all conventional solvents known in the field of enzyme catalysis can be considered.
- All enzymes in EC classes 1 to 6 can fundamentally be considered. The enzyme classification is recommended by the “Nomenclature Committee of the International Union of Biochemistry and Molecular Biology” (IUBMB). The enzyme is either homogeneously dissolved but can also be used as a suspension or as an immobilisate on an inert carrier.
- It was found according to the invention that the presence of ionic liquids in the reaction medium during enzymatically catalysed reactions results in an improvement in the substrate solubility (biocompatibility), an improvement in the enzyme activity, an improvement in the selectivity, a reduction in product inhibition, suppression of side reactions (parallel, consecutive reactions) and/or an increase in enzyme stability. The examples prove that enzymes from different classes can be used, wherein the use of ionic liquids offers significant advantages, such as, for example, an increase in the activity in the case of formate dehydrogenase, a significant increase in the yield in reactions with galactosidase, an increase in the enantioselectivity for lipases and an improvement in the educt volubility for hydrophobic educts.
- According to the invention, the enzyme together with the total quantity of ionic liquid or a part thereof can be used repeatedly or in continuously operated reactors.
- The enzymes can be selected from the class of oxidoreductases for regio- and stereoselective oxidation and reduction, from the class of glycosidases for the synthesis of oligosaccharides, from the class of lipases to obtain optically active products (among others, alcohols, amines, carboxylic acids) and from the class of lyases for synthesis, and hydrolases.
- The method according to the invention can be carried out at temperatures between −10° C. and 130° C., preferably in a temperature range between 10° C. and 80° C., especially preferably in a temperature range between 20° C. and 40° C.
- The method can be carried out in a single-phase fashion or in a multiphase reaction system,
- Some effects arising from the use of ionic liquids as a reaction medium or as a constituent of reaction media for enzymatic reactions will be described below as examples. For example, alcohol dehydrogenases from various sources are used among others for the enzymatic reduction of ketones. The solubility of hydrophobic ketones can be improved by the addition of organic solvents; however, this generally results in a reduction in the enzyme activity and stability (W. Hummel, Biochem. Eng. Biotechnol. 1997, 58, 145; A. Liese, T. Zelinski, M.- R. Kula, H. Kierkels, M. Karutz, U. Kragl, C. Wandrey, J. Mol. Cat. B 1998, 4, 91). In a similar fashion, water-miscible ionic liquids can be added to the reaction medium to increase the educt solubility. For the formate dehydrogenase used for cofactor regeneration, an increase in the reaction rate compared with the purely aqueous system is observed in the same concentration range of the ionic liquid (see Example 1). No deactivation of the enzyme was observed even when the time of influence of the ionic liquid was fairly long. Thus, ionic liquids offer a valuable possibility for increasing the productivity of enzymatic reactions through an increase in the educt concentration. This is especially interesting for barely soluble to very barely soluble educts such as aromatic ketones or steroids.
- For about 20 years glycosidases have not only been used for breaking bonds between saccharides but also for the synthesis of di- and oligosaccharides. Despite many attempts to use water-miscible solvents (leads to reduced enzyme stability), by means of the generally expensive activation of educts, yields no greater than 31% have been obtained even in the most recent studies (J. H. Yoon, J. S. Rhee, Carbohydr. Res. 2000, 327, 377; M. J. Hernaiz, D. H. G. Crout, J. Mol. Cat. B 2000, 10, 403). The main problem in these reactions is the immediately initiated secondary hydrolysis of the product, catalysed by the same enzyme. Surprisingly, this secondary hydrolysis is almost completely suppressed in the presence of ionic liquids with otherwise the same enzyme activity. For the example of β-galactosidase-catalysed synthesis of N-acetyl lactosamine, an important building block for pharmacologically relevant oligosaccharide, it was shown that the presence of ionic liquids increases the yield above 55% when using lactose as an inexpensive donor| A maximum of 30% is achieved without the addition of ionic liquids; however, the product concentration drops rapidly to values of <10% as a result of the secondary hydrolysis. Since the secondary hydrolysis does not take place in the presence of ionic liquids, a simplified reaction process is obtained since it is not necessary to follow the reaction and interrupt it at the maximum product yield. The galactosidage is very stable in the presence of ionic liquids and can be repeatedly used after separation by means of ultrafiltration without any change in the attainable yield and the product formation rate.
- Ionic liquids also offer advantages in reverse hydrolysis for the synthesis of di- and oligosaccharides. In this case, high educt concentrations together with additives, usually organic solvents, are used to reduce the water activity. Here ionic liquids especially offer the advantage of a very good dissolving capacity for carbohydrates. In the enzymatic synthesis of lactose, it was possible to increase the yield by a factor of 2 and reduce the reaction time by a factor of 5 compared with the literature (K. Ajisaka, H. Fujimoto, H. Nishida, Carbohydr. Res. 180, 35-42 (1988)).
- The use of lipases in the presence of organic solvents in single- or two-phase reactions is prior art (G. Carrea, S. Riva, Angew. Chem. 2000, 112, 2312, U. T. Bornscheuer, R. J. Kazlauskas, Hydrolases in Organic Synthesis—Regio- and stereoselective Biotransformations, Wiley-VCH, Weinheim, 1999; A. Liese, K. Seelbach, C. Wandrey, Industrial Biotransformations, Wiley-VCH, Weinheim, 2000; M. C. Parker, S. A. Brown, L. Robertson, N. J. Turner, Chem. Commun. 1998, 2247). However, the enzyme has so far conventionally been separated by filtration and the reaction solution conventionally separated by distillation and the solvent fed back. The use of ionic liquids permits direct distillative separation of the reactands from the reaction mixture even in the presence of the enzyme so that a simplified procedure results. If the reactands possess suitable volatility, this procedure is not limited to lipases. In an investigation of various lipases for racemate splitting in the presence of ionic liquids it was surprisingly established in several cases that the conversion rate and the enantioselectivity are in some cases significantly improved, in individual cases a factor of 5 better. The reaction in tert-butylmethyl ether which is also used as a solvent for lipase-catalysed reactions in industrial processes, is used for comparison.
- The results show that ionic liquids as a reaction medium for enzymatic conversions have numerous advantages compared with the conditions established as the prior art and can be used as biocompatible solvents to specifically influence conversions.
- The invention is described in detail by the following examples without however being restricted to these.
- The following abbreviations were used for the description of components used in the examples:
tert-butylmethylether tBME, MTBE Butyl-methyl-imidazolium PF6 − BMIm+ PF6 − Nonyl-methyl-imidazolium PF6 − NMIm+ PF6 − Butyl-methyl-imidazolium BF4 − BMIm+ BF4 − Hexyl-methyl-imidazolium BF4 − HMIm+ BF4 − Octyl-methyl-imidazolium BF4 − OMIm+ BF4 − 4-methyl-butyl-pyridinium BF4 − 4-MBPy+ BF4 − Triethylammonium-methyl sulphate Et3NH+ MeSO4 − Triethylmethylammonium-methyl Et3NMe+ MeSO4 − sulphate Butylmethyl-pyridinium BF4 − BMPy+ BF4 − Propylammonium-nitrate PrNH3 + NO3 − Methyl-methyl-imidazolium-methyl MMIm+ MeSO4 − sulphate Ethyl-methyl-imidazolium-benzoate EMIm+ PhCO2 − Butyl-methyl-imidazolium-trifluoro BMIm+ CF3SO3 − methane sulphonate (= triflate) Butyl-methyl-imidazolium-bis- BMIm+ (CF3SO2)2N− trifluoromethyl sulphonyl)-imidate - The FDH-catalysed oxidation of formic acid to carbon dioxide by the reduction of nicotinamide adenine dinucleotide (NAD+ to NADH+H+) is used as the test reaction to determine the enzyme activity. In the enzyme assay the increase in NADH with time at 25° C. is detected photometrically at a wavelength of 340 nm.
- Composition of the enzyme assay: 1 ml buffer solution (50 mM triethanolamine hydrochloride, 1 mM dithiothreitol, hydrochloric acid) pH 7 is mixed with 0.1 ml of aqueous sodium formate solution (2.4 M) and 0.1 ml of enzyme solution (0.7 mg/ml, 8.4 U). The enzyme solution already contains the cofactor NAD (6 mM)
- In order to test the influence of water-soluble ionic liquids on the enzyme activity, the volume of the buffer solution in the assay is gradually reduced by 25 vol % and replaced by the ionic liquid.
TABLE 1 NAD reduction by formate dehydrogenase from Candida boidinii; enzyme activity compared with the standard reaction in the buffer solution Ionic liquid 25 vol % 50 vol % 75 vol % MMIm+ MeSO4 − ± + +
+ good to better,
± the same.
- The influence of ionic liquids on the progress of β-Gal-catalysed transgalactosylation starting from lactose and N-acetyl glucosamine is studied. For this purpose concentration-time profiles of this synthesis in the presence and absence of ionic liquids are recorded and compared.
- In each series of tests 10 reactions were started in parallel in 1 ml GC glasses. At 10 minute intervals the reactions are stopped by boiling at 100° C., the reaction solution is filtered (Minisart RC 4 Sartorius injection filter) and the concentration of the reaction components at this time is determined chromatographically (Aminex HPX-87H cation exchange column from BioRad with a corresponding pre-column, 0.006 M sulphuric acid as eluent with a flux of 0.8 ml/min and a column temperature of 65° C. Detection is accomplished using UV at 208 nm and using the refractive index).
- Composition of the reaction mixture: 0.05 ml buffer solution (65 mM KH2PO4, 195 mM K2HPO4) pH 7,3 is mixed with 0.5 ml N-acetyl glucosamine solution (GlcNAc 600 mM or 1.2 M in buffer solution), 0.25 ml lactose solution (250 mM in buffer solution) and 0.2 ml enzyme solution (10 mg/ml in buffer solution).
- By exchanging buffer solution for ionic liquid in the substrate solutions, the fraction of ionic liquid in the reaction medium is gradually increased. The following substrate solutions are thus obtained:
-
- a) 0.50 ml N-acetyl glucosamine solution (600 mM in 1:4 MMIm+ MeSO4 −: buffer solution)
- b) 0.50 ml N-acetyl glucosamine solution (600 mM in 1:4 MMIm+ MeSO4 −: buffer solution) 0.25 ml lactose solution (250 mM in 1:4 MMIm+ MeSO4 −: buffer solution)
- c) 0.50 ml N-acetyl glucosamine solution (1.2 M in 1:2 MMIm+ MeSO4 −: buffer solution) 0.25 ml lactose solution (250 mM in 1:2 MMIm+ MeSO4 −: buffer solution)
- d) 0.50 ml N-acetyl glucosamine solution (600 mM in 1:4 BMIm+ H2PO4 −/Cl−: buffer solution)
TABLE 2 Synthesis of N-acetyl lactosamine by β- galactosidase from Bacillus circulans with and without ionic liquid Lactose/ Yield Yield Reaction Fraction GlcNAc [%] [%] after medium [vol %] ratio after 60 min 100 min Phosphate 1:2.4 5 3 buffer MMIm+ MeSO4 − a) 12.5 1:2.4 40 40 b) 18.75 1:2.4 44 43 c) 25 1:4.8 49 55 (90 min) BMIm+ H2PO4 −/ d) 12.5 1:2.4 39 30 Cl− - 4.4 ml of an ionic liquid in accordance with Table 3 or tert-butylmethyl ether are mixed with 122 μl of vinyl acetate and 54 μl of 1-phenyl ethanol so that a substrate solution with approximately 0.1 mol/l of 1-phenyl ethanol and 0.3 mol/l of vinyl acetate is obtained. Each 1 mg of lyophilised lipase (>120 U/mg) is mixed with 0.4 ml of substrate solution, thoroughly mixed and incubated at 24° C. for 3-4 days, shaking slightly.
- For further processing 100 μl of the reaction formulation is mixed with 1 ml of n-hexane/isopropanol (97.5/2.5 v/v) and mixed thoroughly, This hexane/isopropanol extract is used to determine the concentrations and enantiomer ratios of 1-phenyl ethanol and 1-phenylethyl acetate using HPLC. The conversion and the enantiomer excess were calculated from these concentrations (see Table 3).
- HPLC conditions:
- Column: Guard column Nucleosil C-18 5 μm; 10 mm, 4.6 mm ID;
-
- Preparatory column Chiracel OJ; 50 mm, 4.6 mm ID;
- Separating column Chiracel OJ; 250 mm, 4.6 mm ID
- Eluent: isocratic;
-
- 96.5% (v/v) n-hexane,
- 3.0% (v/v) isopropanol,
- 0.5% (v/v) ethanol
- Flux rate: 1 ml/min
- Temperature: 38° C.
- Detection: UV detector (205 nm)
TABLE 3 Enantioselective acylation of 1-phenyl ethanol, catalysed by lipase from Candida antarctica (Type B): conversion and enantiomer excess in ionic liquids compared to the standard reaction in tert-butylmethyl ether; Ionic liquid/solvent Conversion Enantiomer excess NMIm+ PF6 − ± + BMIm+ BF4 − + + HMIm+ BF4 − ± + OMIm+ BF4 − + + 4-MBP+ BF4 − + + BMIm+ CF3SO3 − + + BMIm+ (CF3SO2)2N− + +
+ good to better,
± the same,
− poor to none.
- Each 5 mg of lyophilised lipase (>30 U/mg) is mixed with 0.4 ml of a substrate solution as in Example 3. The further procedure corresponds to that described in Example 3.
TABLE 4 Enantioselective acylation of 1-phenyl ethanol, catalysed by lipase from Candida antarctica (Type A): Conversion and enantiomer excess in ionic liquids compared to the standard reaction in tert-butylmethyl ether; Ionic liquid/solvent Conversion Enantiomer excess BMIm+ PF6 − + + NMIm+ PF6 − + + BMIm+ BF4 − ± + HMIm+ BF4 − + + OMIm+ BF4 − + ± BMIm+ CF3SO3 − + +
+ good to better,
± the same,
− poor to none.
- Each 3 mg of lyophilised lipase (400 U/mg) is mixed with 0.4 ml of a substrate solution as in Example 3. The further procedure corresponds to that described in Example 3.
TABLE 5 Enantioselective acylation of 1-phenyl ethanol, catalysed by lipase from Pseudomonas sp.: conversion and enantiomer excess in ionic liquids compared to the standard reaction in tert-butylmethyl ether; Ionic liquid/solvent Conversion Enantiomer excess MIm+ PF6 − ± + 4-MBP+ BF4 − ± + BMIm+ CF3SO3 − + + BMIm+ (CF3SO2)2N− + +
+ good to better,
± the same,
− poor to none.
- Each 5 mg of lyophilised lipase (>20 U/mg) is mixed with 0.4 ml of a substrate solution as in Example 3. The further procedure corresponds to that described in Example 3.
TABLE 6 Enantioselective acylation of 1-phenyl ethanol, catalysed by lipase from Alcaligines sp.: conversion and enantiomer excess in ionic liquids compared to the standard reaction in tert-butylmethyl ether, Ionic liquid/solvent Conversion Enantiomer excess BMIm+ PF6 − ± + BMIm+ BF4 − ± + BMIm+ BF4 − ± + OMIm+ BF4 − ± + 4-MBP+ BF4 − ± + BMIm+ CF3SO3 − ± +
+ good to better,
± the same,
− poor to none.
- 600 mg of lyophilised lipase (approx. 10 U/mg) is mixed with 4 ml of ionic liquid (BMIm+ (CF3SO2)2N−), 1.2 ml of vinyl acetate and 0.7 ml 1-phenyl ethanol and thoroughly mixed. The reaction mixture is incubated for 40 min at 40° C.
- The non-converted educts and the reaction product 1-phenyl acetate ie then distilled off (85° C., 0.06 mbar).
- The enzyme/ionic liquid mixture is cooled, re-mixed with 1.2 ml of vinyl acetate and 0.7 ml of 1-phenyl ethanol and again incubated for 40 min at 40° C.
- The reaction sequence involving incubation and distilling off can be repeated many times without the lipase activity diminishing.
- 100 mmol/l of glucose, 20 mmol/l of galactose and 2 mg/ml of galactosidase are incubated at 35° C. in a mixture of water and MMIm MeSO4 for 24 h. The reaction is stopped by boiling for 10 minutes at 100° C., the reaction solution is filtered (Minisart RC 4 Sartorius injection filter) and the concentration of the reaction components at this time is determined chromatographically (Aminex HPX-87H cation exchange column from BioRad with corresponding preparatory column, 0.006 M sulphuric acid as eluent with a flux of 0.8 ml/min and a column temperature of 65° C. Detection is accomplished using UV at 208 nm and using the refractive index).
- The fraction of ionic liquid is increased from 0 to 100 percent by volume. As a result of water traces in the ionic liquid and the educts, a water content of 0.6% is obtained for 100% ionic liquid. After 24 hours, the conversion no longer increases. The following lactose yields are obtained depending on the quantity of ionic liquid:
Fraction of ionic liquid in % Yield [%] 0 0 10 0 20 0 30 4 40 12 50 15 60 15 70 16 80 16 90 16 100 17
Claims (13)
1. A method for the conversion of substances in the presence of enzymes as a catalyst in a reaction medium comprising at least one ionic liquid, wherein the enzyme is selected from the group of oxidoreductases, lipases, galactosidases, glycosidases, lyases and enzymes in EC class 6.
2. The method according to claim 1 , characterised in that the ionic liquid has the general formula
[A]n +[Y]n−,
where
n=1 or 2 and the anion [Y]n− is selected from the group comprising tetrafluoroborate ([BF4]−), tetrachloroborate ([BCl4]−), hexafluorophosphate ([PF6]−), hexafluoroantimonate ([SbF6]−), hexafluoroarsenate ([AsF6]−), tetrachloroaluminate ([AlCl4]−), trichlorozincate [(ZnCl3]−), dichlorocuprate, sulphate ([SO4]2−), carbonate ([CO3]2−), fluorosulphonate, [R′—COO]−, [R′—SO3]− or [(R′—SO2)2N]−, and R′ is a linear or branched aliphatic or alicyclic alkyl containing 1 to 12 carbon atoms or a C5-C18-aryl, C5-C18-aryl-C1-C6-alkyl or C1-C6-alkyl-C5-C18-aryl radical that can be substituted by halogen atoms, the cation [A]+ is selected from
[NR1R2R3R]+,
[PR1R2R3R]+,
quaternary ammonium cations having the general formula
[NR1R2R3R]+,
phosphonium cations having the general formula
[PR1R2R3R]+,
imidazolium cations having the general formula
where the imidizole nucleus can be substituted with at least one group selected from C1-C6-alkyl, C1-C6-alkoxy, C1-C6-aminoalkyl, C5-C12-aryl or C5-C12-aryl-C1-C6-alkyl groups,
pyridinium cations having the general formula
where the pyridine nucleus can be substituted with at least one group selected from C1-C6-alkyl, C1-C6-alkoxy, C1-C6-aminoalkyl, C5-C12-aryl or C5-C12-aryl-C1-C6-alkyl groups,
pyrazolium cations having the general formula
where the pyrazole nucleus can be substituted with at least one group selected from C1-C6-alkyl, C1-C6-alkoxy, C1-C6-aminoalkyl, C5-C12-aryl or C5-C12-aryl-C1-C6-alkyl groups,
and triazolium cations having the general formula
where the triazole nucleus can be substituted with at least one group selected from C1-C6-alkyl, C1-C6-alkoxy, C1-C6-aminoalkyl, C5-C12-aryl or C5-C12-aryl-C1-C6-alkyl groups,
and the radicals R1, R2, R3 are selected independently of one another from the group consisting of
hydrogen;
linear or branched, saturated or unsaturated, aliphatic or alicyclic alkyl groups with 1 to 20 carbon atoms;
heteroaryl, heteroaryl-C1-C6-alkyl groups with 3 to 8 carbon atoms in the heteroaryl radical and at least one heteroatom selected from N, O and S which can be substituted with at least one group selected from C1-C6-alkyl groups and/or halogen atoms;
aryl-, aryl-C1-C6-alkyl groups with 5 to 12 carbon atoms in the aryl radical which if necessary can be substituted with at least one C1-C6-alkyl group and/or one halogen atom.
3. The method according to any one of the preceding claims, characterised in that the fraction of the ionic liquid in the reaction medium is 0.1 to 99.9 percent by volume.
4. The method according to any one of the preceding claims, characterized in that in addition to the ionic liquid, the reaction medium also contains a further solvent.
5. The method according to any one of the preceding claims, characterized in that the further solvent is water or an organic solvent.
6. The method according to any one of the preceding claims, characterised in that the reaction is carried out at temperatures of −10° C. to 130° C.
7. The method according to any one of the preceding claims, characterised in that the reaction is carried out in a single-phase fashion or in a multiphase reaction system.
8. A composition comprising an enzyme selected from the groups of oxidoreductases, lipases, galactosidases, glycosidases, lyases and enzymes in EC class 6 and at least one ionic liquid.
9. The composition according to claim 8 , characterised in that the ionic liquid is defined as in claim 2 .
10. The composition according to claim 8 or claim 9 , characterised in that it additionally contains a substrate.
11. The composition according to any one of claims 8 to 10 , characterised in that it contains the ionic liquid as a reaction medium or as a constituent of the reaction medium.
12. Use of ionic liquids as a reaction medium or as a constituent of the reaction medium for enzymatically catalysed reactions, wherein the enzyme is selected from the group of oxidoreductases, lipases, galactosidases, glycosidases, lyases and enzymes in EC class 6.
13. The use according to claim 12 as a reaction medium or as a constituent of the reaction medium in reverse hydrolysis for the synthesis of di- and oligosaccharides.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/440,321 US20060211096A1 (en) | 2000-11-08 | 2006-05-23 | Enzyme catalysis in the presence of ionic liquids |
US12/119,214 US7754462B2 (en) | 2000-11-08 | 2008-05-12 | Enzyme catalysis in the presence of ionic liquids |
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP00124195A EP1205555A1 (en) | 2000-11-08 | 2000-11-08 | Enzymatic catalysis in the presence of ionic liquids |
EPEP00124195.9 | 2000-11-08 | ||
PCT/EP2001/012869 WO2002038784A1 (en) | 2000-11-08 | 2001-11-07 | Enzyme catalysis in the presence of ionic liquids |
US10/416,067 US20040096932A1 (en) | 2000-11-08 | 2001-11-07 | Enzyme catalysis in the presence of ionic liquids |
US11/440,321 US20060211096A1 (en) | 2000-11-08 | 2006-05-23 | Enzyme catalysis in the presence of ionic liquids |
Related Parent Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/012869 Continuation WO2002038784A1 (en) | 2000-11-08 | 2001-11-07 | Enzyme catalysis in the presence of ionic liquids |
US10416067 Continuation | 2001-11-07 | ||
US10/416,067 Continuation US20040096932A1 (en) | 2000-11-08 | 2001-11-07 | Enzyme catalysis in the presence of ionic liquids |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/119,214 Continuation US7754462B2 (en) | 2000-11-08 | 2008-05-12 | Enzyme catalysis in the presence of ionic liquids |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060211096A1 true US20060211096A1 (en) | 2006-09-21 |
Family
ID=8170307
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/416,067 Abandoned US20040096932A1 (en) | 2000-11-08 | 2001-11-07 | Enzyme catalysis in the presence of ionic liquids |
US11/440,321 Abandoned US20060211096A1 (en) | 2000-11-08 | 2006-05-23 | Enzyme catalysis in the presence of ionic liquids |
US12/119,214 Expired - Fee Related US7754462B2 (en) | 2000-11-08 | 2008-05-12 | Enzyme catalysis in the presence of ionic liquids |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/416,067 Abandoned US20040096932A1 (en) | 2000-11-08 | 2001-11-07 | Enzyme catalysis in the presence of ionic liquids |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US12/119,214 Expired - Fee Related US7754462B2 (en) | 2000-11-08 | 2008-05-12 | Enzyme catalysis in the presence of ionic liquids |
Country Status (8)
Country | Link |
---|---|
US (3) | US20040096932A1 (en) |
EP (2) | EP1205555A1 (en) |
JP (1) | JP4195610B2 (en) |
AT (1) | ATE331803T1 (en) |
AU (1) | AU2002220685A1 (en) |
DE (1) | DE50110361D1 (en) |
ES (1) | ES2267856T3 (en) |
WO (1) | WO2002038784A1 (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070161095A1 (en) * | 2005-01-18 | 2007-07-12 | Gurin Michael H | Biomass Fuel Synthesis Methods for Increased Energy Efficiency |
US8455421B2 (en) | 2008-09-01 | 2013-06-04 | Expelliere Int Ltd | Compositions and methods for the removal of chewing gum residues from substrates |
CN105492623A (en) * | 2013-08-30 | 2016-04-13 | 积水医疗株式会社 | Method for measuring cholesterol in high-density lipoprotein, and reagent for use in said method |
Families Citing this family (31)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10201778A1 (en) * | 2002-01-17 | 2003-07-31 | Studiengesellschaft Kohle Mbh | Process for carrying out enzymatic reactions in ionic solvents |
US20040077519A1 (en) * | 2002-06-28 | 2004-04-22 | The Procter & Gamble Co. | Ionic liquid based products and method of using the same |
DE10240098B4 (en) * | 2002-08-30 | 2006-04-06 | Roche Diagnostics Gmbh | Process for the synthesis and selective biocatalytic modification of peptides, peptide mimetics and proteins |
GB0300595D0 (en) * | 2003-01-10 | 2003-02-12 | Univ Cambridge Tech | Ionic liquids |
GB0407908D0 (en) * | 2004-04-07 | 2004-05-12 | Univ York | Ionic liquids |
AU2011202949B2 (en) * | 2004-04-07 | 2011-11-24 | Worn Again Technologies Limited | Ionic liquids comprising nitrogen containing cations |
JP2005298404A (en) * | 2004-04-12 | 2005-10-27 | Mitsubishi Rayon Co Ltd | Method for producing carboxylic acid ester |
WO2006005409A1 (en) * | 2004-07-14 | 2006-01-19 | Degussa Ag | Enzymatic reactions in the presence of ionic additives |
US20060090777A1 (en) * | 2004-11-01 | 2006-05-04 | Hecht Stacie E | Multiphase cleaning compositions having ionic liquid phase |
US7776810B2 (en) | 2004-11-01 | 2010-08-17 | The Procter & Gamble Company | Compositions containing ionic liquid actives |
US20060094616A1 (en) * | 2004-11-01 | 2006-05-04 | Hecht Stacie E | Ionic liquids derived from surfactants |
US7939485B2 (en) * | 2004-11-01 | 2011-05-10 | The Procter & Gamble Company | Benefit agent delivery system comprising ionic liquid |
US7737102B2 (en) | 2004-11-01 | 2010-06-15 | The Procter & Gamble Company | Ionic liquids derived from functionalized anionic surfactants |
US20060090271A1 (en) * | 2004-11-01 | 2006-05-04 | Price Kenneth N | Processes for modifying textiles using ionic liquids |
US20060094621A1 (en) * | 2004-11-01 | 2006-05-04 | Jordan Glenn T Iv | Process for improving processability of a concentrate and compositions made by the same |
JP2008520227A (en) * | 2004-11-18 | 2008-06-19 | メディジーン リミテッド | Soluble bifunctional protein |
US7786065B2 (en) * | 2005-02-18 | 2010-08-31 | The Procter & Gamble Company | Ionic liquids derived from peracid anions |
WO2007106943A1 (en) | 2006-03-22 | 2007-09-27 | Ultraclean Fuel Pty Ltd | Process for removing sulphur from liquid hydrocarbons |
WO2008009445A1 (en) * | 2006-07-21 | 2008-01-24 | Roche Diagnostics Gmbh | A reagent for digestion of hemoglobin |
JP2010516265A (en) | 2007-01-23 | 2010-05-20 | ビーエーエスエフ ソシエタス・ヨーロピア | Process for producing glucose by enzymatic hydrolysis of cellulose pretreated with ionic liquids with polyatomic anions |
JP2010516266A (en) * | 2007-01-23 | 2010-05-20 | ビーエーエスエフ ソシエタス・ヨーロピア | Process for producing glucose by enzymatic hydrolysis of cellulose obtained from lignocellulose-containing material using ionic liquids having polyatomic anions |
DE102007044379A1 (en) | 2007-09-17 | 2009-03-26 | Forschungszentrum Jülich GmbH | Procedure for the conversion of substrates e.g. organic sulfides, ketones and amino acids, to products by a combined electrochemical and catalytic process in a reaction medium containing ionic liquid` |
DE102007058394A1 (en) * | 2007-12-03 | 2009-06-04 | Bayer Technology Services Gmbh | Process for the production of fuels from biomass |
DE102008061866B9 (en) | 2008-12-15 | 2012-12-20 | Forschungszentrum Jülich GmbH | Use of ionic liquids |
CN103080329B (en) * | 2010-07-19 | 2016-08-03 | 阿尔拉食品公司 | Compositions containing galacto-oligosaccharide and production method thereof |
JP2017018135A (en) * | 2010-07-19 | 2017-01-26 | アルラ フーズ アムバArla Foods Amba | Galacto-oligosaccharide-containing composition and method of producing the same |
KR101935367B1 (en) | 2012-07-26 | 2019-01-04 | 삼성전자주식회사 | Method for enhancing efficiency and sensitivity in nucleic acid amplification from biological materials using ionic liquids |
US9441169B2 (en) | 2013-03-15 | 2016-09-13 | Ultraclean Fuel Pty Ltd | Process for removing sulphur compounds from hydrocarbons |
SG10201709956YA (en) | 2013-03-15 | 2018-01-30 | Ultraclean Fuel Pty Ltd | Process for removing sulphur compounds from hydrocarbons |
JP7129767B2 (en) * | 2016-08-22 | 2022-09-02 | ミヨシ油脂株式会社 | Reaction solvent for biocatalyst and method for reacting substrate with biocatalyst using same |
CN107937470B (en) * | 2017-12-12 | 2021-03-16 | 江南大学 | Method for synthesizing phytosterol ester in ionic liquid system by enzyme method |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3681197A (en) | 1969-01-02 | 1972-08-01 | Clarence T Smith | Method and solution for maintaining biological activity in enzymes |
US3986930A (en) * | 1974-05-28 | 1976-10-19 | Dainippon Pharmaceutical Co., Ltd. | Lipase activity determining method and reagent |
SE451849B (en) * | 1985-12-11 | 1987-11-02 | Svenska Sockerfabriks Ab | VIEW TO SYNTHETIZE GYCLOSIDIC BINDINGS AND USE OF THIS RECEIVED PRODUCTS |
KR910008732B1 (en) * | 1990-01-22 | 1991-10-19 | 한국과학기술 연구원 | Process for preparing saccaride derivatives for using reverse hydrolysis of enzyine |
BR9712537A (en) | 1996-10-18 | 2002-09-10 | Procter & Gamble | Detergent compositions and method of washing clothes in a domestic washing machine |
JP2000245496A (en) * | 1999-03-04 | 2000-09-12 | Meiji Milk Prod Co Ltd | Production of fucosyl oligosaccharide |
-
2000
- 2000-11-08 EP EP00124195A patent/EP1205555A1/en not_active Withdrawn
-
2001
- 2001-11-07 JP JP2002542099A patent/JP4195610B2/en not_active Expired - Fee Related
- 2001-11-07 WO PCT/EP2001/012869 patent/WO2002038784A1/en active IP Right Grant
- 2001-11-07 DE DE50110361T patent/DE50110361D1/en not_active Revoked
- 2001-11-07 US US10/416,067 patent/US20040096932A1/en not_active Abandoned
- 2001-11-07 EP EP01993696A patent/EP1332221B1/en not_active Revoked
- 2001-11-07 ES ES01993696T patent/ES2267856T3/en not_active Expired - Lifetime
- 2001-11-07 AT AT01993696T patent/ATE331803T1/en not_active IP Right Cessation
- 2001-11-07 AU AU2002220685A patent/AU2002220685A1/en not_active Abandoned
-
2006
- 2006-05-23 US US11/440,321 patent/US20060211096A1/en not_active Abandoned
-
2008
- 2008-05-12 US US12/119,214 patent/US7754462B2/en not_active Expired - Fee Related
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070161095A1 (en) * | 2005-01-18 | 2007-07-12 | Gurin Michael H | Biomass Fuel Synthesis Methods for Increased Energy Efficiency |
US8455421B2 (en) | 2008-09-01 | 2013-06-04 | Expelliere Int Ltd | Compositions and methods for the removal of chewing gum residues from substrates |
CN105492623A (en) * | 2013-08-30 | 2016-04-13 | 积水医疗株式会社 | Method for measuring cholesterol in high-density lipoprotein, and reagent for use in said method |
EP3040421A1 (en) * | 2013-08-30 | 2016-07-06 | Sekisui Medical Co., Ltd. | Method for measuring cholesterol in high-density lipoprotein, and reagent for use in said method |
EP3040421A4 (en) * | 2013-08-30 | 2017-03-29 | Sekisui Medical Co., Ltd. | Method for measuring cholesterol in high-density lipoprotein, and reagent for use in said method |
CN105492623B (en) * | 2013-08-30 | 2019-01-15 | 积水医疗株式会社 | Reagent used in method for determination of cholesterol and this method in high-density lipoprotein |
Also Published As
Publication number | Publication date |
---|---|
WO2002038784B1 (en) | 2003-03-20 |
EP1332221A1 (en) | 2003-08-06 |
ES2267856T3 (en) | 2007-03-16 |
WO2002038784A1 (en) | 2002-05-16 |
US20040096932A1 (en) | 2004-05-20 |
JP4195610B2 (en) | 2008-12-10 |
AU2002220685A1 (en) | 2002-05-21 |
DE50110361D1 (en) | 2006-08-10 |
EP1205555A1 (en) | 2002-05-15 |
EP1332221B1 (en) | 2006-06-28 |
US20080299623A1 (en) | 2008-12-04 |
ATE331803T1 (en) | 2006-07-15 |
JP2004513639A (en) | 2004-05-13 |
US7754462B2 (en) | 2010-07-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7754462B2 (en) | Enzyme catalysis in the presence of ionic liquids | |
US7695942B2 (en) | Enzymatic conversion of epoxides | |
JP2691986B2 (en) | Process for producing optically active compound having pyridine skeleton | |
Singh et al. | Enantioselective transesterification of racemic phenyl ethanol and its derivatives in organic solvent and ionic liquid using Pseudomonas aeruginosa lipase | |
Jeong et al. | Lipase-catalyzed reaction in the packed-bed reactor with continuous extraction column to overcome a product inhibition | |
EP0529085B1 (en) | Process for producing optically active 3-chloro-1-phenyl-1-propanol and derivative thereof | |
JPH11215995A (en) | Production of optically active 2-halo-1-(substituted phenyl) ethanol | |
US5493063A (en) | Process for optical resolution of 1,2-diol derivatives | |
JP3587569B2 (en) | Method for producing optically active 1- (3,4-dimethoxyphenyl) -2-propanol | |
Honda et al. | Enzymatic preparation of D-β-acetylthioisobutyric acid and cetraxate hydrochloride using a stereo-and/or regioselective hydrolase, 3, 4-dihydrocoumarin hydrolase from Acinetobacter calcoaceticus | |
JPS615794A (en) | Production of optically active benzyl alcohol derivative | |
EP1966385A2 (en) | A process for the production of an optically enriched tertiary alcohol | |
EP0148272B1 (en) | Process for producing optically active benzyl alcohol compounds | |
JP3732535B2 (en) | Process for producing optically active α-methylalkanedicarboxylic acid-ω-monoester and its enantiomer diester | |
KR100567899B1 (en) | Method of preparing trans-1S,2S-2-bromo-1-indanyl acetate by enzymatic method | |
CA2321450A1 (en) | Process for producing (r)-2-hydroxy-1-phenoxypropane derivative | |
TWI388667B (en) | Enzyme dynamic segmentation method | |
JPH10150998A (en) | Production of n-benzyl-3-pyrrolidinol | |
JP3545442B2 (en) | Method for producing optically active 4- (2-halo-1-hydroxyethyl) -2-trifluoromethylthiazole | |
JP2003299495A (en) | Method for producing optically active monoester of 3- methylglutaric acid | |
JP3970898B2 (en) | Process for producing optically active α-methylalkanedicarboxylic acid-ω-monoester and its enantiomer diester | |
KR100567108B1 (en) | Method of preparing trans-1S,2S-1-azido 2-indanol and trans-1R,2R-1-azido 2-indanyl acetate by enzymatic method | |
Alfani et al. | Control of enzyme properties in supramolecular systems | |
JP2006061112A (en) | Method for producing optically active 2-(cyclopentylmethyl)-malonic acid monoester | |
US20220098623A1 (en) | Method for producing (1r,3r)-3-(trifluoromethyl)cyclohexan-1-ol and intermediate thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |